D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co. is an investment firm founded in 1988 by David E. Shaw, who had been a computer science professor at Columbia University. It started over a small bookstore in downtown New York and became a pioneer in computational finance, using math models and software to profit from market anomalies. Its funds rely heavily on computer-driven methods and its own technology to support fundamental research, and it also makes private equity investments in areas such as technology, wind power and real estate. Shaw ran the firm until 2001, then stepped back from daily involvement to focus on D. E. Shaw Research, where he is chief scientist and heads a research group in computational biochemistry. In the mid-1990s it also set up a brokerage and founded the email provider Juno Online Services. An Executive Committee chaired by Anne Dinning leads the firm.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$436M |
| 2 |
AbbVie
ABBV
|
+$407M |
| 3 |
Johnson & Johnson
JNJ
|
+$295M |
| 4 |
Gilead Sciences
GILD
|
+$267M |
| 5 |
Starbucks
SBUX
|
+$230M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$407M |
| 2 |
Booking.com
BKNG
|
+$400M |
| 3 |
Citigroup
C
|
+$314M |
| 4 |
SHPG
Shire pic
SHPG
|
+$276M |
| 5 |
PayPal
PYPL
|
+$257M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 23.09% |
| 2 | Technology | 17.04% |
| 3 | Healthcare | 13.44% |
| 4 | Consumer Discretionary | 13.35% |
| 5 | Financials | 7.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Apple
AAPL
$5.09T
| $1.11B | 1.43% |
23,293,900
+2,275,304
| +11% | +$96.5M |
2013 Q2
23 quarters
|
|
2
Lowe's Companies
LOW
$116B
| $955M | 1.23% |
8,721,822
-131,794
| -1% | -$13.2M |
2013 Q2
23 quarters
|
|
3
Meta Platforms (Facebook)
META
$1.63T
| $793M | 1.02% |
4,757,695
-727,213
| -13% | -$116M |
2013 Q2
23 quarters
|
|
|
CELG
4
DELISTED
Celgene Corp
CELG
| $693M | 0.9% |
7,347,569
+258,429
| +4% | +$22.6M |
2013 Q2
23 quarters
|
|
5
Qualcomm
QCOM
$198B
| $668M | 0.86% |
11,710,220
+3,717,214
| +47% | +$201M |
2013 Q2
23 quarters
|
|
6
PUT
Amazon
AMZN
$2.63T
| $619M | 0.8% |
6,950,000
-2,272,000
| -25% | -$189M |
2013 Q2
23 quarters
|
|
7
VeriSign
VRSN
$27.4B
| $588M | 0.76% |
3,236,541
-333,745
| -9% | -$57.3M |
2013 Q2
23 quarters
|
|
8
Colgate-Palmolive
CL
$74.3B
| $540M | 0.7% |
7,877,579
+706,929
| +10% | +$45.7M |
2014 Q3
18 quarters
|
|
9
Merck
MRK
$361B
| $496M | 0.64% |
6,252,107
+823,706
| +15% | +$61.6M |
2013 Q2
23 quarters
|
|
|
10
AbbVie
ABBV
$514B
| $491M | 0.63% |
6,094,735
+4,979,335
| +446% | +$407M |
2013 Q2
23 quarters
|
|
11
eBay
EBAY
$53.9B
| $481M | 0.62% |
12,939,598
-70,426
| -0.5% | -$2.44M |
2013 Q2
23 quarters
|
|
|
12
Johnson & Johnson
JNJ
$662B
| $469M | 0.61% |
3,354,881
+2,201,273
| +191% | +$295M |
2013 Q2
23 quarters
|
|
13
Oracle
ORCL
$423B
| $468M | 0.6% |
8,704,864
-2,959,743
| -25% | -$151M |
2014 Q1
20 quarters
|
|
|
14
Pfizer
PFE
$171B
| $461M | 0.6% |
11,438,234
+10,886,229
| +1,972% | +$436M |
2013 Q2
23 quarters
|
|
15
Fidelity National Information Services
FIS
$19.2B
| $453M | 0.59% |
4,005,374
+1,264,459
| +46% | +$135M |
2013 Q2
23 quarters
|
|
16
Microsoft
MSFT
$3.94T
| $446M | 0.58% |
3,782,936
-579,310
| -13% | -$63.2M |
2013 Q2
23 quarters
|
|
|
ATVI
17
DELISTED
Activision Blizzard
ATVI
| $436M | 0.56% |
9,578,754
+4,455,926
| +87% | +$201M |
2017 Q3
6 quarters
|
|
|
18
Amazon
AMZN
$2.63T
| $436M | 0.56% |
4,894,180
+1,153,000
| +31% | +$95.9M |
2013 Q2
23 quarters
|
|
19
Wayfair
W
$16.5B
| $430M | 0.56% |
2,897,254
+1,084,947
| +60% | +$142M |
2016 Q3
10 quarters
|
|
20
Alibaba
BABA
$248B
| $425M | 0.55% |
2,327,812
-738,524
| -24% | -$124M |
2018 Q4
1 quarter
|
|
|
21
Gilead Sciences
GILD
$205B
| $416M | 0.54% |
6,402,500
+4,014,025
| +168% | +$267M |
2013 Q2
23 quarters
|
|
22
ConocoPhillips
COP
$180B
| $403M | 0.52% |
6,041,938
+3,144,824
| +109% | +$212M |
2013 Q2
23 quarters
|
|
23
Medtronic
MDT
$124B
| $401M | 0.52% |
4,406,272
+2,255,449
| +105% | +$202M |
2016 Q3
10 quarters
|
|
24
NXP Semiconductors
NXPI
$67B
| $394M | 0.51% |
4,458,969
-2,773,099
| -38% | -$244M |
2013 Q2
23 quarters
|
|
25
Block Inc
XYZ
$46.2B
| $374M | 0.48% |
4,986,321
+2,756,233
| +124% | +$200M |
2016 Q4
9 quarters
|
|
Similar funds
D.E. Shaw & Co's Q1 2019 Portfolio in Review
As of Q1 2019, D.E. Shaw & Co held 4,169 positions worth $77.4B, up 6.6% from $72.6B the previous quarter. Its ten largest holdings account for 9% of the portfolio.
D.E. Shaw & Co withdrew a net $2.66B in Q1 2019, closing 617 positions and reducing 1,599 holdings. Its most notable exit was Shire pic, an estimated $276M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.
Against the trend, D.E. Shaw & Co opened a new position in Lyft worth $159M.
- D.E. Shaw & Co's largest Q1 2019 buy was Lyft: 2,245,851 shares worth $159M.
- D.E. Shaw & Co added most to Pfizer in Q1 2019, an estimated $436M increase.
- D.E. Shaw & Co's biggest Q1 2019 reduction was Bristol-Myers Squibb, cutting an estimated $407M.
- D.E. Shaw & Co fully exited Shire pic in Q1 2019, selling an estimated $276M.
- D.E. Shaw & Co's ten largest holdings make up 9% of its $77.4B portfolio in Q1 2019.
- D.E. Shaw & Co opened 447 new positions and closed 617 in Q1 2019.
- D.E. Shaw & Co's portfolio value rose 6.6% quarter-over-quarter to $77.4B.
Based on D.E. Shaw & Co's 13F filing for Q1 2019, filed 15 May 2019.